Symbicort pMDI 80/2.25 μg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Symbicort pMDI 80/2.25 μg, covering 2017-04-10 to 2017-04-10. Get the full timeline:
Most recent: Clinical Trial Update: A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg [Phase 3]